Evaluation of HIV/HBV Co-Infected Cases
Yıl: 2015 Cilt: 6 Sayı: 4 Sayfa Aralığı: 439 - 442 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022
Evaluation of HIV/HBV Co-Infected Cases
Öz: Amaç: İnsan immun yetmezlik virusu (HIV) ile enfekte hastalarda ortak bulaş yollarının olması nedeniyle Hepatit B virüs (HBV) koenfeksiyonları birlikteli- ği sık görülmektedir. Bu çalışmanın amacı, HIV ile enfekte olgularda HBV enfeksiyonu sıklığının belirlenmesi ve olguların retrospektif olarak incelenmesidir. Gereç ve Yöntem: Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniğinde 2002-2012 yılları arasında takip edilen 180 HIV ile enfekte olgu retrospektif olarak incelendi. Bulgular: Olguların yaş ortalaması 45.6 (27-73) olup, 5i erkek, 3ü kadındı. Yapılan çalışmada toplam 8 (%4.4) olguda HBV enfeksiyonu tespit edildi. Tartışma: HIV enfeksiyonlu olgularda HBV birlikteliğinde hastalığın gidişatı ve tedavisi farklılıklar göstermektedir. HIV enfeksiyonu saptanmış olgularda HBV serolojisi araştırılmalıdır.
Anahtar Kelime: HIV/HBV Koenfeksiyonlu Olguların Değerlendirilmesi
Öz: Aim: Human immune deficiency virus (HIV) infections and hepatitis B virus (HBV) coinfections are common because of common transmission route. We aimed to investigate the seroprevalence of HBV infection in HIV infected cases and to evaluate these patients. Material and Method: In this study, 180 HIV infected patients who were admitted to the Infectious Diseases and Clinical Microbiology Department between 2002-2012 were retrospectively evaluated. Results:The average age of the patients was 45,6 (27-73) years and five of them were males and three were females.In this study, 8 (4.4 %) cases HBV infection detected. Discussion: The treatment of chronic hepatitis differ in HIV infected patients. All patients with HIV infection should be screened for HBV.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Tosun S. Ulusal hepatit B aşılaması. Viral Hepatit Dergisi 2006;11(3):117-25.
- 2. Badur S. 2007 yılında AIDS: nereden nereye geldik? Ankem Derg 2007;21(2):1-6.
- 3. Kaptan F. İnsan immün yetmezlik virüsü ile enfekte 128 olgunun retrospektif olarak değerlendirilmesi. Turkiye Klinikleri J Med Sci 2011;31(3):525-33.
- 4. Koziel MJ, Peters MG. Viral hepatitis in HIV infection. N Engl Med 2007;356:1445- 54.
- 5. Puoti M, Torti C, Bruno R, Filice G, Carosi G. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006;44(1):65-70.
- 6. Thio CL, Netski DM, Myung J, Seaberg EC, Thomas DL. Changes in hepatitis B virus DNA levels with acute HIV infection. Clin Infect Dis 2004;38(7):1024-9.
- 7. Shire NJ, Rouster SD, Stanford SD, Blackard JT, Martin CM, Fichtenbaum CJ et al. The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients. J Acquir Immune Defic Syndr 2007;44(3):309-14.
- 8. Çalık Başaran N.Ünal S. HIV, Hepatit C ve Hepatit B Koenfeksiyonları. Turkiye Klinikleri J Int Med Sci 2007;3(28):45-53.
- 9. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. Journal of Hepatology 2009;50:22742.
- 10. Taşyaran MA. HBV İnfeksiyonu Epidemiyolojisi. Kılıçturgay K, Badur S, Viral Hepatit. Viral Hepatitle Savaşım Derneği. İstanbul; 2001.p.121-8.
- 11.Özsoy MF, Emekdaş G, Pasha A ve ark. Sağlık çalışanlarında hepatit B ve hepatit C seroprevalansı. Viral Hepatit Dergisi 2000;2:71-4.
- 12. Köse Ş, Yalçınkaya T. HIV-1 Subtiplerinin Dağılımı Türk Mikrobiyol Cem Derg 2011;41(3):116-9.
- 13. Ural S, Kaptan F, Türker N, Örmen B, El S ,Coşkun NA, Demir C. İnsan immün yetmezlik virusuyla infekte olgularda hepatit b virusu ve hepatit c virusu infeksiyonu seroprevalansı. Klimik Dergisi 2010;23(3):100-4.
- 14. Kumbasar-Karaosmanoğlu H, Aydın AÖ, İnce ER. HIV/AIDS hastalarında hepatit B ve hepatit C seroprevalansı. Viral Hepatit Dergisi 2009;14(2):53-6.
- 15. Denis F, Adjide CC, Rogez S, Delpeyroux C, Rogez JP, Weinbreck P. Seroprevalence of HBV, HCV and HDV hepatitis markers in 500 patients infected with the human immunodeficiency virus. Pathol Biol (Paris) 1997;45(9):701-8.
- 16. Law WP, Dore GJ, Duncombe CJ, Mahanontharit A, Boyd MA, Ruxrungtham A et al. Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIVNAT Cohort Thailand, 1996-2001. AIDS 2003;17(15):2191-9.
- 17. Lincoln D, Petoumenos K, Dore GJ. Australian HIV Observational Database: HIV/ HBV and HIV/ HCV coinfection, and outcomes following highly active antiretroviral therapy. HIV Med 2003;4(3):241-9.
- 18. Tremeau-BravardA, Ogbukagu IC, Ticao CJ, Abubakar JJ. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja. Nigeria Afr Health Sci 2012;12(3):312-7.
- 19. Jain M, Chakravarti A, Verma B, Halla P. Seroprevalence of hepatitis viruses in patients infected with the human immunodeficiency virus. Indian J Pathol Microbiol 2009;52(1):17-9.
- 20. Aurpibul L, Lumbiganon P, Kolasaraksa P, Hansudewechakul R, Sa-Nguanmoo P, Taeprasert P et al. HIV and Hepatitis B coinfection among perinatally HIV-infected Thai adolescents. Pediatr Infect Dis J 2012;31(9):943-7.
- 21. Dziuban EJ, Marton SA, Hughey AB, Mbingo TL, Draper HR, Schutze GE. Seroprevalence of hepatitis B in a cohort of HIV-infected children and adults in Swaziland. Int J STD AIDS 2013;24(7):561-5.
- 22. Bello Corredor M, Rodríguez Lay Lde L, Gutiérrez Moreno A, Sariego Frómeta S, Montalvo Villalba MC, Sánchez Sol A. Detection of hepatitis B and hepatitis C markers in HIV positive patients, 2000-2004. Rev Cubana Med Trop 2005;57(3):212-3.
- 23. Kaptan F, Örmen B, Türker N, El S, Ural S, Vardar İ. İnsan immün yetmezlik virüsü ile enfekte 128 olgunun retrospektif olarak değerlendirilmesi. Turkiye Klinikleri J Med Sci 2011;31(3):525-33.
- 24. Wandeler G, Gsponer T, Bihl F, Bernasconi E, Cavassini M, Kovari H et al. Hepatitis B virus ınfection ıs associated with ımpaired ımmunological recovery during antiretroviral therapy in the swiss HIV cohort study. J Infect Dis 2013;208(9):1454- 8.
- 25. Thio CL, Seaberg EC, Skolasky R Jr, Phair J, Visscher B, Muñoz A et al. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study Lancet 2002;360(9349):1921-6.
- 26. Puoti M, Cozzi-Lepri A, Paraninfo G, Arici C, Moller NF, Lundgren JD et al. HBVHIV International Intercohort Study Group. Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis. Antivir Ther 2006;11(5):567-74.
- 27. Nelson M, Portsmouth S, Stebbing J, Atkins M, Barr A, Matthews G et al. An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals. AIDS 2003;17(1):7-10.
- 28. Jain MK, Comanor L, White C, Kipnis P, Elkin C, Leung K et al. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response. J Viral Hepat 2007;14(3):176-82.
- 29. Kosi L, Reiberger T, Payer BA, Grabmeier-Pfistershammer K, Strassl R, Rieger A, Peck-Radosavljevic M. Five-year on-Treatment Efficacy of Lamivudine-, Tenofovir- and Tenofovir + Emtricitabine-based HAART in HBVHIV-coinfected. J Viral Hepat 2012;19(11):801-10.
- 30. Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P et al. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand. Hepatology 2008;48(4):1062-9.
| APA | İNCİ A, Fincanci M, SOYSAL F (2015). Evaluation of HIV/HBV Co-Infected Cases. , 439 - 442. |
| Chicago | İNCİ Ayşe,Fincanci Muzaffer,SOYSAL Ferda Evaluation of HIV/HBV Co-Infected Cases. (2015): 439 - 442. |
| MLA | İNCİ Ayşe,Fincanci Muzaffer,SOYSAL Ferda Evaluation of HIV/HBV Co-Infected Cases. , 2015, ss.439 - 442. |
| AMA | İNCİ A,Fincanci M,SOYSAL F Evaluation of HIV/HBV Co-Infected Cases. . 2015; 439 - 442. |
| Vancouver | İNCİ A,Fincanci M,SOYSAL F Evaluation of HIV/HBV Co-Infected Cases. . 2015; 439 - 442. |
| IEEE | İNCİ A,Fincanci M,SOYSAL F "Evaluation of HIV/HBV Co-Infected Cases." , ss.439 - 442, 2015. |
| ISNAD | İNCİ, Ayşe vd. "Evaluation of HIV/HBV Co-Infected Cases". (2015), 439-442. |
| APA | İNCİ A, Fincanci M, SOYSAL F (2015). Evaluation of HIV/HBV Co-Infected Cases. Journal of Clinical and Analytical Medicine, 6(4), 439 - 442. |
| Chicago | İNCİ Ayşe,Fincanci Muzaffer,SOYSAL Ferda Evaluation of HIV/HBV Co-Infected Cases. Journal of Clinical and Analytical Medicine 6, no.4 (2015): 439 - 442. |
| MLA | İNCİ Ayşe,Fincanci Muzaffer,SOYSAL Ferda Evaluation of HIV/HBV Co-Infected Cases. Journal of Clinical and Analytical Medicine, vol.6, no.4, 2015, ss.439 - 442. |
| AMA | İNCİ A,Fincanci M,SOYSAL F Evaluation of HIV/HBV Co-Infected Cases. Journal of Clinical and Analytical Medicine. 2015; 6(4): 439 - 442. |
| Vancouver | İNCİ A,Fincanci M,SOYSAL F Evaluation of HIV/HBV Co-Infected Cases. Journal of Clinical and Analytical Medicine. 2015; 6(4): 439 - 442. |
| IEEE | İNCİ A,Fincanci M,SOYSAL F "Evaluation of HIV/HBV Co-Infected Cases." Journal of Clinical and Analytical Medicine, 6, ss.439 - 442, 2015. |
| ISNAD | İNCİ, Ayşe vd. "Evaluation of HIV/HBV Co-Infected Cases". Journal of Clinical and Analytical Medicine 6/4 (2015), 439-442. |
